Insulin-Related Amyloidosis
- Age-Related Macular Degeneration
- Alzheimer’s Disease
- Amyotrophic Lateral Sclerosis
- Autism Spectrum Disorder
- Chronic Mental Diseases
- Chronic Traumatic Encephalopathy
- Conjunctival Amyloidosis
- Corticobasal Degeneration
- Creutzfeldt–Jakob Disease
- Dementia With Lewy Bodies
- Dentatombral-Pallidoluysian Atrophy
- Desmin-Related Cardiomyopathy
- Dialysis-Related Amyloidosis
- Familial Alzheimer’s Disease
- Familial Amyloidotic Cardiomyopathy
- Familial Amyloidotic Polyneuropathy
- Familial Amyotrophic Lateral Sclerosis
- Familial British Dementia
- Familial Danish Dementia
- Familial Fatal Insomnia
- Familial Mediterranean Fever
- Familial Oculoleptomeningel Amyloidosis
- Familial Parkinson’s Disease
- Finnish Hereditary Systemic Amyloidosis
- Frontotemporal Dementia
- Gerstmann–Sträussler–Scheinker Syndrome
- HIV Infection
- Hereditary Cerebral Amyloid Angiopathy
- Hereditary Non-Neuropathic Systemic Amyloidosis
- Hereditary Renal Amyloidosis
- Huntington’s Disease
- Inclusion Body Myositis
- Insulin-Related Amyloidosis
- Isolated Atrial Amyloidosis
- Medullary Carcinoma Of The Thyroid
- Multiple Systems Atrophy
- Parkinson’s Disease
- Pick’s Disease
- Preeclampsia
- Primary Amyloidosis
- Progressive Supranuclear Palsy
- Prostatic Amyloidosis
- Pure Autonomic Failure
- Senile Systemic Amyloidosis
- Spinal And Bulbar Muscular Atrophy
- Spinal Cord Injury And Traumatic Brain Injury
- Spinocerebellar Ataxia Types 1, 2, 3, 6, 7, And 17
- Systemic (Reactive) Aa Amyloidosis
- Type-2 Diabetes Mellitus
Insulin-related amyloidosis, or injection-localized amyloidosis, is a rare condition that occurs in diabetic patients who do not alter the site of insulin injection. In such cases, insulin aggregates and forms subcutaneous amyloid at the site of the injection. The condition is not considered dangerous systemically and the amyloid can be removed surgically.